Alessandro Zuddas Selected Research

Alessandro Zuddas Research Topics

Disease

41	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2024 - 01/2004
5	Mental Disorders (Mental Disorder) 05/2023 - 01/2006
4	Oppositional Defiant Disorder 10/2020 - 03/2006
3	Nausea 01/2022 - 09/2009
2	Bipolar Disorder (Manic Depressive Psychosis) 02/2023 - 11/2022
2	Mood Disorders (Mood Disorder) 02/2023 - 08/2011
2	Mania (Manias) 11/2022 - 08/2011
2	Schizophrenia (Dementia Praecox) 11/2022 - 08/2011
2	Depressive Disorder (Melancholia) 11/2022 - 01/2008
2	Vomiting 01/2022 - 09/2009
2	Headache (Headaches) 01/2022 - 09/2013
2	Conduct Disorder (Conduct Disorders) 12/2021 - 12/2014
1	Hypertriglyceridemia 06/2023
1	Hypercholesterolemia 06/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2023
1	Weight Gain 06/2023
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 01/2023
1	Hyperphagia (Overeating) 01/2023
1	Learning Disabilities (Learning Disability) 12/2022
1	Dizziness (Lightheadedness) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Antisocial Personality Disorder (Antisocial Personality) 12/2021
1	Neuroinflammatory Diseases 01/2021
1	Autistic Disorder (Autism) 11/2018
1	Autism Spectrum Disorder 10/2015
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2013
1	Nasopharyngitis 09/2013
1	Anorexia 09/2013
1	Intellectual Disability (Idiocy) 08/2011
1	Psychotic Disorders (Schizoaffective Disorder) 08/2011
1	Abdominal Pain (Pain, Abdominal) 09/2009
1	Neurobehavioral Manifestations 03/2005
1	Neuroblastoma 07/2002
1	Basal Ganglia Diseases (Basal Ganglia Disease) 07/2002
1	Dopa-responsive Dystonia 07/2002

Drug/Important Bio-Agent (IBA)

18	Methylphenidate (Ritalin)FDA LinkGeneric 02/2024 - 01/2004
12	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2018 - 07/2004
11	Lisdexamfetamine Dimesylate FDA Link 01/2018 - 09/2013
4	Biomarkers (Surrogate Marker)IBA 06/2023 - 10/2015
3	Antipsychotic Agents (Antipsychotics)IBA 06/2023 - 08/2011
3	mesoglycanIBA 02/2023 - 01/2006
3	ProdrugsIBA 12/2014 - 10/2013
2	Olanzapine (Zyprexa)FDA Link 06/2023 - 08/2011
2	Lurasidone Hydrochloride FDA Link 06/2023 - 11/2022
2	LithiumIBA 02/2023 - 11/2022
2	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2023 - 08/2011
2	AmphetaminesIBA 01/2018 - 03/2017
2	Amphetamine (Amfetamine)FDA LinkGeneric 10/2017 - 09/2013
2	Therapeutic UsesIBA 10/2017 - 09/2013
2	Dopamine (Intropin)FDA LinkGeneric 03/2005 - 07/2002
1	Molindone (Molindone Hydrochloride)FDA Link 06/2023
1	ziprasidone (Geodon)FDA Link 06/2023
1	carbetocinIBA 01/2023
1	4- (3,4- dichlorophenyl)- 1,2,3,4- tetrahydronaphthalen- 1- amineIBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2022
1	gamma-Linolenic AcidIBA 12/2022
1	Docosahexaenoic AcidsIBA 12/2022
1	Food Additives (Food Additive)IBA 12/2022
1	Eicosapentaenoic AcidIBA 12/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	VortioxetineIBA 01/2022
1	Histidine (L-Histidine)FDA Link 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	KynurenineIBA 01/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	DiamondIBA 10/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2018
1	Clonidine (ST 155)FDA LinkGeneric 10/2017
1	Guanfacine (Tenex)FDA LinkGeneric 10/2017
1	Bupropion (Wellbutrin)FDA LinkGeneric 10/2017
1	Modafinil (Provigil)FDA Link 10/2017
1	Dexmethylphenidate Hydrochloride FDA LinkGeneric 10/2017
1	Adenosine Monophosphate (AMP)IBA 03/2017
1	Nonesterified Fatty Acids (NEFA)IBA 03/2013
1	Risperidone (Risperdal Consta)FDA LinkGeneric 08/2011
1	Aripiprazole (Abilify)FDA Link 08/2011
1	Quetiapine Fumarate (Seroquel)FDA Link 08/2011
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2008
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2005
1	CatecholaminesIBA 03/2005
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 07/2002
1	sapropterin (tetrahydrobiopterin)FDA Link 07/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 12/2018 - 09/2013
4	Therapeutics 12/2021 - 09/2009
2	Combined Modality Therapy 01/2018 - 10/2017
2	Cognitive Training 03/2015 - 03/2013
2	Secondary Prevention 08/2004 - 07/2004
1	Transitional Care 05/2023
1	Neurofeedback 03/2013